Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review.

MLA

Dauvergne, Maxime, et al. “Renal Diseases Secondary to Interferon-β Treatment: A Multicentre Clinico-Pathological Study and Systematic Literature Review.” Clinical Kidney Journal, vol. 14, no. 12, Dec. 2021, pp. 2563–72. EBSCOhost, https://doi.org/10.1093/ckj/sfab114.

APA

Dauvergne, M., Buob, D., Rafat, C., Hennino, M.-F., Lemoine, M., Audard, V., Chauveau, D., Ribes, D., Gall, E. C.-L., Daugas, E., Pillebout, E., Vuiblet, V., Boffa, J.-J., & Group, F. N. (2021). Renal diseases secondary to interferon-β treatment: a multicentre clinico-pathological study and systematic literature review. Clinical Kidney Journal, 14(12), 2563–2572. https://doi.org/10.1093/ckj/sfab114

Chicago

Dauvergne, Maxime, David Buob, Cédric Rafat, Marie-Flore Hennino, Mathilde Lemoine, Vincent Audard, Dominique Chauveau, et al. 2021. “Renal Diseases Secondary to Interferon-β Treatment: A Multicentre Clinico-Pathological Study and Systematic Literature Review.” Clinical Kidney Journal 14 (12): 2563–72. doi:10.1093/ckj/sfab114.